Immunological studies in chronic lymphocytic leukemia.-I. Elucidation of subset heterogeneity

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Leukemia·2013

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.

British journal of cancer·2012

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Leukemia·2011

Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase.

Scandinavian journal of clinical and laboratory investigation·2003

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Leukemia·2003

Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.

European journal of haematology·2003

From standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms.

Leukemia research·2026

Efficacy of R-GDP therapy as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.

Leukemia research·2026

Circulating NK-cell counts improve prognostic stratification of the PINKE model in extranodal NK/T-cell lymphoma: a retrospective cohort study.

Leukemia research·2026

Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.

Leukemia research·2026

Stemness-driven INTS7 overexpression links metabolic comorbidity to chemoresistance in acute myeloid leukemia with type 2 diabetes.

Leukemia research·2026

SLC1A5 and NUMA1 are potential regulators and therapeutic targets of ferroptosis in diffuse large B-cell lymphoma.

Leukemia research·2026

Underdocumentation of laboratory-defined acute kidney injury in internal medicine wards: a retrospective cohort study.

Renal failure·2026

Aberrant Expression of Multiple T-Cell Markers in Primary Cutaneous Follicle Center Lymphoma: A Rare Case Report.

Journal of cutaneous pathology·2026

Monomeric hapten dissociates FcεRI-evoked STIM1-Orai1 interaction and immediately terminates Ca2+ influx in rat basophilic leukemia cells.

Biochemical and biophysical research communications·2026

A rapid lateral flow immunoassay for infectious spleen and kidney necrosis virus (ISKNV).

Talanta·2026

Evidence of Chikungunya Virus Reinfection in Two Patients With Lupus During the 2024-2025 Outbreak on Reunion Island.

Open forum infectious diseases·2026

A Real-Time Image-Based Co-Culture Assay to Quantify Tumor-Infiltrating Lymphocyte-Mediated Apoptotic Killing of Patient-Derived Tumor Organoids.

Journal of visualized experiments : JoVE·2026

Related Experiment Videos

Immunological studies in chronic lymphocytic leukemia.-I. Elucidation of subset heterogeneity

Related Concept Videos

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase.

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.

From standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms.

Efficacy of R-GDP therapy as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.

Circulating NK-cell counts improve prognostic stratification of the PINKE model in extranodal NK/T-cell lymphoma: a retrospective cohort study.

Cladribine-based salvage therapy in relapsed/refractory AML: A multicenter retrospective study.

Stemness-driven INTS7 overexpression links metabolic comorbidity to chemoresistance in acute myeloid leukemia with type 2 diabetes.

SLC1A5 and NUMA1 are potential regulators and therapeutic targets of ferroptosis in diffuse large B-cell lymphoma.

Underdocumentation of laboratory-defined acute kidney injury in internal medicine wards: a retrospective cohort study.

Aberrant Expression of Multiple T-Cell Markers in Primary Cutaneous Follicle Center Lymphoma: A Rare Case Report.

Monomeric hapten dissociates FcεRI-evoked STIM1-Orai1 interaction and immediately terminates Ca2+ influx in rat basophilic leukemia cells.

A rapid lateral flow immunoassay for infectious spleen and kidney necrosis virus (ISKNV).

Evidence of Chikungunya Virus Reinfection in Two Patients With Lupus During the 2024-2025 Outbreak on Reunion Island.

A Real-Time Image-Based Co-Culture Assay to Quantify Tumor-Infiltrating Lymphocyte-Mediated Apoptotic Killing of Patient-Derived Tumor Organoids.

Related Experiment Videos

Immunological studies in chronic lymphocytic leukemia.-I. Elucidation of subset heterogeneity

Related Concept Videos

Related Articles